Greenwich LifeSciences Inc. (GLSI): Price and Financial Metrics
GET POWR RATINGS... FREE!
GLSI Stock Price Chart Interactive Chart >
GLSI Price/Volume Stats
|Current price||$45.16||52-week high||$158.07|
|Prev. close||$43.69||52-week low||$3.26|
|Day high||$45.23||Avg. volume||306,716|
|50-day MA||$41.72||Dividend yield||N/A|
|200-day MA||$38.27||Market Cap||585.68M|
Greenwich LifeSciences Inc. (GLSI) Company Bio
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Most Popular Stories View All
GLSI Latest News Stream
|Loading, please wait...|
GLSI Latest Social Stream
View Full GLSI Social Stream
Latest GLSI News From Around the Web
Below are the latest news stories about Greenwich LifeSciences Inc that investors may wish to consider to help them evaluate GLSI as an investment opportunity.
STAFFORD, Texas, September 13, 2021--Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
STAFFORD, Texas, September 09, 2021--Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments
STAFFORD, Texas, September 07, 2021--Greenwich LifeSciences to Participate in Citi’s 16th Annual Biopharma Virtual Conference
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
It's Thursday morning and investors keeping track of the pre-market will want to make sure they check out this list of movers!
GLSI Price Returns